New Edge Advisors, LLC Glaukos Corp Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$45.44 - $71.21 $61,162 - $95,848
-1,346 Reduced 96.63%
47 $3,000
Q1 2023

May 12, 2023
SELL
$43.88 - $52.48 $2,457 - $2,938
-56 Reduced 3.86%
1,393 $69,000
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $59,148 - $83,679
1,449 New
1,449 $63,000

Others Institutions Holding GKOS

# of Institutions
341
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.12B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email